Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a revolutionary new method to improve compact gene-editing tools known as base ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

A 19-year-old Canadian man becomes the first human cured through prime gene editing after doctors corrected a rare genetic ...

Editas Medicine (NASDAQ:EDIT) executives outlined the company’s in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore O’Neill ...

The U.S. Food and Drug Administration approved the first cell-based gene therapies for sickle cell disease, including the ...

For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and consumer-facing startups. Gene editing, once confined to rare diseases and lab ...

Two studies published in Nature Medicine June 11 contribute to a small body of literature suggesting cells edited with CRISPR-Cas9 may cause cancer. Here are five things to know about the studies and ...

A Bay Area biochemist has launched a new company to further research on gene editing on human embryos. Lucas Harrington said the research will focus on using the technology to prevent genetic disease ...

A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...

Crispr Therapeutics Ag (NASDAQ:CRSP) is one of the Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Biotech company Crispr ...

Tools like CRISPR-Cas9 are creating new opportunities for innovation in St. Louis, as well as risks around IP protection and regulation.